Literature DB >> 2782348

Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?

N E Madinger1, J S Greenspoon, A G Ellrodt.   

Abstract

The maternal death rate and rate of preterm delivery associated with pneumonia during pregnancy have not decreased since the introduction of antibiotics four decades ago. We retrospectively reviewed 25 cases of pneumonia during pregnancy; these cases occurred among 32,179 deliveries. Medical complications included: bacteremia, 16%; empyema, 8%; atrial fibrillation, 4%; respiratory failure necessitating mechanical ventilation, 20%. Obstetric complications occurring during the pneumonia episode included: preterm labor, 44%; preterm delivery, 36%. A patient with cystic fibrosis died; one stillbirth and two neonatal deaths occurred. Underlying maternal disease was significantly associated with maternal medical complications (p = 0.023) and preterm delivery (p = 0.012). Significant medical and obstetric complications continue to occur frequently despite modern antimicrobial, tocolytic, and supportive therapy. Underlying maternal disease, including acquired immunodeficiency syndrome and cystic fibrosis, was associated with preterm delivery and neonatal and maternal death.

Entities:  

Mesh:

Year:  1989        PMID: 2782348     DOI: 10.1016/0002-9378(89)90373-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  44 in total

Review 1.  Perinatal bacterial infection: an update.

Authors:  T J Yeagley; J E Tolosa; V K Bhutani
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

Review 2.  Women with cystic fibrosis and their potential for reproduction.

Authors:  F P Edenborough
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 3.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

4.  Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor.

Authors:  Juan Pedro Kusanovic; Jimmy Espinoza; Roberto Romero; Debra Hoppensteadt; Jyh Kae Nien; Chong Jai Kim; Offer Erez; Eleazar Soto; Jawed Fareed; Sam Edwin; Tinnakorn Chaiwerapongsa; Nador G Than; Bo Hyun Yoon; Ricardo Gomez; Zoltan Papp; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-06

Review 5.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 6.  Preterm birth due to maternal infection: Causative pathogens and modes of prevention.

Authors:  M V Pararas; C L Skevaki; D A Kafetzis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

Review 7.  The Microbiome and Complement Activation: A Mechanistic Model for Preterm Birth.

Authors:  Alexis B Dunn; Anne L Dunlop; Carol J Hogue; Andrew Miller; Elizabeth J Corwin
Journal:  Biol Res Nurs       Date:  2017-01-11       Impact factor: 2.522

8.  Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.

Authors:  Jan Walter; Mwiya Mwiya; Nancy Scott; Prisca Kasonde; Moses Sinkala; Chipepo Kankasa; Shuaib Kauchali; Grace M Aldrovandi; Donald M Thea; Louise Kuhn
Journal:  J Infect Dis       Date:  2006-10-19       Impact factor: 5.226

9.  Dysregulation of maternal serum adiponectin in preterm labor.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Chia-Ling Nhan-Chang; Cristiano Jodicke; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

Review 10.  The change of asthma course during pregnancy.

Authors:  Joan C Gluck
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.